1 / 10

PARP Inhibitors Market to grow at a CAGR of 15% during 2019 - 2026

"The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period," forecasts the FMI report.

Imran123
Download Presentation

PARP Inhibitors Market to grow at a CAGR of 15% during 2019 - 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PARP Inhibitors Market is Expected to Grow at a CAGR of Around 15% During 2019 - 2026 Feb 2020 Report Id : REP-GB-3197 Published On : Feb-2020 Category : Healthcare, Pharmaceuticals & Medical Devices www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitiveframework,and future markettrends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing– the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Email: hari.t@futuremarketinsights.com www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 2 © 2019 Future Market Insights, All Rights Reserved

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 3 © 2019 Future Market Insights, All Rights Reserved

  4. PARP Inhibitors Market Analysis PARP Inhibitors Market is Expected to Grow at a CAGR of Around 15% During 2019 – 2026 The global poly ADP ribose polymerase (PARP) inhibitors market is poised for an exponential growth at a CAGR of 15% during the forecast period (2019-2026). Strong demand from the flourishing pharmaceutical industries a key contributor for this growth projection. PARP inhibitors have gained noteworthy momentum owing to increased awareness about efficacy in terms of treating different types of cancer. "The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period," forecasts the FMI report.  Key Takeawaysof PARP Inhibitors Market Study • Olaparib is projected to dominate the global PARP inhibitors market owing to its applications in ovarian cancer, breast cancer, and pancreatic cancer. • A number of PARP inhibitors are up for imminent approval owing to a new drug application process. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 4 © 2019 Future Market Insights, All Rights Reserved

  5. PARP Inhibitors Market Analysis • PARP inhibitors are rapidly gaining traction as a new care standard of ovarian cancer treatment following platinum chemotherapy. • North America and Europe are projected to remain the dominant regional PARP inhibitors markets owing to better access to new technology and reimbursement policies. • Centralizing access to virtual and physical care with the aid of startups, research institutes and government bodies will play a key role in role for the future. PARP Inhibitors Market - Top Growth Drivers • The rising burden of the different cancer types is a key driver behind the demand for PARP inhibitors. • The superior efficacy of PARP inhibitors over that of other cancer treatments is expected to drive revenue generation in the forecast period. • Faster approval of PARP inhibitor drugs are also anticipated to drive adoption rates, as demand rises. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 5 © 2019 Future Market Insights, All Rights Reserved

  6. PARP Inhibitors Market Analysis PARP Inhibitors Market - Key Restraints • High costs related to clinical trials, insurance coverage, and testing for drug-drug interactions is a key restraint, particularly for emerging players. • The nascent nature of the PARP inhibitors market also builds the risk of such dosages not being included in select electronic records. Competitive Landscape Some of the key market players profiled in the report include, but are not limited to TESARO Inc., AbbVie Inc., Pfizer Inc., AstraZeneca, and CLOVIS ONCOLOGY. Mergers and acquisitions are the key developmental strategies being adopted by leading market players, as the market is projected to remain in a consolidated stage through the forecast period. Such moves will enable manufacturers to widen their scope of regional product offerings. For instance, TESARO Inc., was acquired by Glaxo Smith Kline plc which allowed the latter to expand its product portfolio with the inclusion of Zejula (Niraparib) PARP inhibitor. Source: https://www.accesswire.com/577142/PARP-Inhibitor-Sales-to-Exhibit-Significant-CAGR- Through-2026-Investments-in-Cures-for-Cancer-to-Drive-Wider-Adoption-Reports-Future-Market- Insights www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 6 © 2019 Future Market Insights, All Rights Reserved

  7. PARP Inhibitors Market Analysis More about the Report The 200-page study offers an in-depth market forecast and analysis on PARP inhibitors market. The major categories encompassed by the report include drug (olaparib, niraparib, rucaparib, and talazoparib), indication (ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across seven regions (Middle East & Africa, Oceania, Europe, Latin America, South Asia, East Asia, and North America). Explore Extensive Coverage of FMI's Healthcare, Pharmaceuticals and Medical Devices Landscape • Juvenile Idiopathic Arthritis Diagnostics Market • Oscillating Positive Expiratory Pressure (OPEP) Devices Market About Future Market Insights (FMI) Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries FMI is headquartered in London, the global financial capital, and has delivery centers in U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 7 © 2019 Future Market Insights, All Rights Reserved

  8. PARP Inhibitors Market Analysis • PARP inhibitors are rapidly gaining traction as a new care standard of ovarian cancer treatment following platinum chemotherapy. • North America and Europe are projected to remain the dominant regional PARP inhibitors markets owing to better access to new technology and reimbursement policies. • Centralizing access to virtual and physical care with the aid of startups, research institutes and government bodies will play a key role in role for the future. PARP Inhibitors Market - Top Growth Drivers • The rising burden of the different cancer types is a key driver behind the demand for PARP inhibitors. • The superior efficacy of PARP inhibitors over that of other cancer treatments is expected to drive revenue generation in the forecast period. • Faster approval of PARP inhibitor drugs are also anticipated to drive adoption rates, as demand rises. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 8 © 2019 Future Market Insights, All Rights Reserved

  9. PARP Inhibitors Market Analysis Contact: Abhishek Budholiya Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Future Market Insights Click here to Order a free sample www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 9 © 2019 Future Market Insights, All Rights Reserved

  10. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 10 © 2019 Future Market Insights, All Rights Reserved

More Related